|
|
|
|
|
| |
|
| |
|
| |
| Featured Interview |
|
|
| A Closer Look at cGMP Methods for Cannabinoid Molecules |
With the recent approval by the U.S. Food and Drug Administration of the first drug containing cannabidiol (CBD), it is clear that the pharmaceutical industry is poised to join the cannabis rush. However, one big hurdle that pharmaceutical companies must address is the current good manufacturing methods (cGMPs) used to extract and microencapsulate cannabinoid molecules. George Anastassov, the CEO of AXIM Biotech, has been doing research in this area and recently spoke to us about the cGMPs his company has achieved, their significance to the market, and plans for the future.
Read more » |
|
|
|
|
|
|
| SUBSCRIBE |
| Subscribers can enjoy each full issue of Cannabis Science and Technology in print, or via the digital edition. |
| |
|
| |
|
|
|
|
|
| |
|
| |
| News |
|
|
| FDA Approves First Drug Containing CBD |
The U.S. Food and Drug Administration (FDA) recently approved the drug Epidiolex, which contains cannabidiol (CBD), as an oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy—Lennox-Gastaut syndrome and Dravet syndrome—in patients two years of age and older (1).
Read more » |
|
|
|
|
|
|
| |
|
|
